$1.40
-0.12-7.89%
Pre-Market: 8:41 AM EDT
15 minutes delayed
InflaRx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of InflaRx using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.26 | $-0.21 | -23.8 % |
Mar 2024 | 2024-05-08 | $-0.18 | $-0.24 | 25.0 % |
Dec 2023 | 2024-03-21 | $-0.30 | $-0.20 | -50.0 % |
Sep 2023 | 2023-11-01 | $-0.14 | $-0.25 | 44.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $6.84K | $80.00K | -91.4 % |
Mar 2024 | 2024-05-08 | $39.14K | $1.36M | -97.1 % |
Dec 2023 | 2024-03-21 | $2.46K | $1.40M | -99.8 % |
Sep 2023 | 2023-11-01 | $66.18K | $2.55M | -97.4 % |
InflaRx (IFRX) is scheduled to report earnings on October 30, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.26, which missed the estimate of $-0.21.
The Actual Revenue was $6.8K, which missed the estimate of $80K.
Browse earnings estimates, EPS, and revenue on all stocks.